Apolipoprotein B and Interleukin 1 Receptor Antagonist: Reversing the Risk of Coronary Heart Disease
Fangkun Yang, Ning Huangfu, Jiaxi Shen, Pengpeng Su, Lujie Zhu, Hanbin Cui, Shuai Yuan
This study uses Mendelian randomization to show IL-1Ra increases CHD risk, which is reversed by apolipoprotein B adjustment and lifestyle interventions.
Frontiers in Endocrinology · Oct 24, 2023Peer-reviewedGenetics